The results of a recent stem cell research indicate that stem cells from amniotic fluid could be used to treat a fatal intestinal disease, necrotising enterocolitis, among premature newborns.
Dr Paolo De Coppi, from University College London's Institute of Child Health, and team, conducted animal trials. Rats with the intestinal disease were injected with amniotic stem cells. A week later, it was found that rats injected with the stems cells showed increased survival rate with reduced inflammation of the intestine.
The current treatment option for necrotising enterocolitis is surgery to remove the inflamed tissue. Researchers opine that with further trials, newborns could be efficiently treated with stem cells and the survival rates could be drastically improved.